Cutting edge: Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity

Journal of Immunology

Volumn 174, Issue 8, 2005, Pages 4470-4474

  Jodo, Satoshi ^a   Pidiyar, Vyankatesh J ^b   Xiao, Sheng ^b   Furusaki, Akira ^a   Sharma, Rahul ^b   Koike, Takao ^a   Ju, Shyr Te ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; PROLINE; COMPLEMENTARY DNA; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; GENE DELETION; MONKEY; MOUSE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRENGTH; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL STRAIN 3T3; CELL STRAIN COS1; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LEUKEMIA CELL LINE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; COS CELLS; CYTOPLASM; CYTOTOXICITY, IMMUNOLOGIC; DNA, COMPLEMENTARY; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SEQUENCE DELETION;

EID: 18344371455     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.8.4470     Document Type: Article

References (15)

1. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
2. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
3. Bonfoco, E., P. M. Stuart, T. Brunner, T. Lin, T. S. Griffith, Y. Gao, H. Nakajima, P. A. Henkart, T. A. Ferguson, and D. R. Green. 1998. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9:711.
4. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
5. Wei, Y., K. Chen, G. C. Sharp, H. Yagita, and H. Braley-Mullen. 2001. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. J. Immunol. 167:6678.
6. Pinkoski, M. J., T. Brunner, D. R. Green, and T. Lin. 2000. Fas and Fas ligand in gut and liver. Am. J. Physiol. 278:G354.
7. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7.
8. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. 1998. Down-regulation of Fas ligand by shedding. Nat. Med. 4:31.
9. Strehlow, D., S. Jodo, and S.-T Ju. 2000. Retroviral membrane display of apoptocic effector molecules. Proc. Nat. Acad. Sci. USA 97:4209.
10. Jodo, S., S. Xiao, A. Hohlbaum, D. Strehlow, A. Marshak-Rathstein, and S.-T. Ju. 2001. Apoptosis-inducing membrane vesicles: a novel agent with unique properties. J. Biol. Chem. 276:39938.
11. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
12. Ghadimi, M. P., Sanzenbacher, R. Thiede, B. Wenzel, J. Jing, Q. Plomann, M. Borkhard, A. D. Kabelitz, and O. Janssen. 2002. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). FEBS Lett. 519:50.
13. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
14. Blott, E. J., G. Bossi, R. Clark, M. Zvelebil, and G. M. Griffiths. 2001. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114:2405.
15. Xiao, S., U. S. Deshmukh, S. Jodo, T. Koike, R. Sharma, R. Furusaki, S-s. J. Sung, and S-T. Ju. 2004. Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail: evidence for translational regulation and against FasL retention in secretory lysosomes. J. Immunol. 173:5095.